Amgen, Inc.

AMGN
NASDAQ
Company profile


Market capMega (144.42B)
Company CEORobert A. Bradway

Amgen, Inc.

AMGN
NASDAQ
Company profile


Market capMega (144.42B)
Company CEORobert A. Bradway
$243.06Price snapshot
$5.8Annual dividend
2.63 %Dividend yield
13.34%Dividend growth (3y)
N/ATraling P/E
-Forward P/E
-Payout ratio
-EPS

AMGN DIVIDEND PAYOUT HISTORY

Loading...

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K.

Bowes, Jr., Franklin Pitcher Johnson, Jr., George B.

PRICE HISTORY Amgen, Inc.

Loading price stock history...

Amgen, Inc. latest news

Loading latest news...